How MRD Testing Supports Ovarian Cancer Patients: Holly’s Story

Dr. James Duke’s Head & Neck Cancer Story

Anj’s Breast Cancer Story

MRD Testing vs. Traditional Cancer Monitoring: What’s the Difference?

Understanding Hereditary Cancer Risks in Ovarian Cancer

How MRD Testing Helps Monitor Ovarian Cancer Recurrence

A Rare Cancer, A Powerful Tool: What the New Guidelines Mean for Merkel Cell Carcinoma Patients

How MRD Testing Supports Colorectal Cancer Patients: Jason’s Story and the Importance of Regular Monitoring

Medicare Expands Coverage of Signatera for Patients with Lung Cancer

How to Use Natera’s Patient Portal to Manage Your Cancer Care

What Is MRD Testing and How Can It Help Monitor Cancer Recurrence?

Natera at SABCS 2024: What It Means for Breast Cancer Survivors

How to Talk to Your Doctor About Signatera for Lung Cancer

Learn how to talk to your doctor about Signatera for lung cancer recurrence monitoring. Understand the benefits of ctDNA testing, how it detects recurrence early, and why it’s vital for personalized c

Understanding the BESPOKE CRC Study: Your Path to Confident Cancer Monitoring

Event Highlight: SMFM 43rd Annual Pregnancy Meeting

NCCN Guideline Updates for Hereditary Cancer Screening

A Genetic Counselor Helps a Couple Navigate Growing a Family

Findings from the first 1,000 tests using the Renasight™ test’s broad kidney gene panel

Get Ahead of Cancer: How Cancer Previvors Protect Their Health